Lnt transfers an acyl group from sn-1-glycerophospholipids to apolipoproteins via a thioester intermediate . Structural studies of E. coli Lnt homologs reveal:
A dynamic periplasmic "arm" regulating substrate access to the active site .
Conformational changes triggered by substrate binding, enabling acyl transfer .
In V. eiseniae, Lnt’s activity is vital for:
Lipoprotein maturation: Triacylation of lipoproteins ensures proper membrane localization .
Host-symbiont interactions: Lipoproteins mediate signaling in earthworm embryos, where V. eiseniae resides .
Recombinant V. eiseniae Lnt is primarily used in:
ELISA-based assays: Detecting lipoprotein modifications in bacterial membranes .
Functional studies: Investigating antibiotic susceptibility linked to defective lipoprotein biogenesis (e.g., increased outer membrane permeability in lnt mutants) .
Comparative enzymology: Contrasting Lnt mechanisms across Gram-negative bacteria (e.g., Acinetobacter, Mycobacteria) .
lnt deletion in Acinetobacter species causes cell envelope defects, antibiotic hypersensitivity, and altered morphology .
V. eiseniae Lnt mutants show reduced natural transformation efficiency, implicating lipoproteins in DNA uptake via type IV pili .
Unlike E. coli Lnt, V. eiseniae Lnt tolerates host-associated genomic rearrangements without losing catalytic efficiency .
Substrate specificity for C16 and C19:0 fatty acids mirrors mycobacterial Lnt, suggesting evolutionary conservation in lipid metabolism .
Research priorities include:
KEGG: vei:Veis_2158
STRING: 391735.Veis_2158
Verminephrobacter eiseniae Apolipoprotein N-acyltransferase (lnt) is a membrane-bound enzyme that catalyzes N-acylation using phospholipids as acyl donors, transferring a third acyl group to bacterial lipoproteins. The recombinant form is produced as a truncated protein spanning residues 1-536 of the full-length sequence.
The enzyme can be identified by the following molecular characteristics:
| Property | Details |
|---|---|
| Species | Verminephrobacter eiseniae (strain EF01-2) |
| UniProt ID | A1WJU9 |
| Gene | lnt (ordered locus: Veis_2158) |
| Expression Region | Residues 1–536 |
| Post-Translational Modifications | Predicted diacylglycerol attachment and N-terminal acylation |
| KEGG Identifier | vei:Veis_2158 |
| STRING Identifier | 391735.Veis_2158 |
Structurally, the enzyme contains a catalytic cysteine residue (analogous to Cys387 in E. coli Lnt) that is critical for forming a thioester intermediate during acyl transfer. Crystal structures of the homologous E. coli Lnt reveal dynamic loops that regulate substrate access, suggesting a conserved mechanism in V. eiseniae Lnt.
The enzymatic function of Lnt involves a multi-step mechanism for lipoprotein maturation. The process begins with the enzyme recognizing diacylated lipoprotein precursors and facilitating the transfer of a third acyl group to the N-terminal cysteine residue. This conversion from diacylated to triacylated forms is crucial for proper lipoprotein function.
The catalytic mechanism relies on a conserved cysteine residue that forms a thioester intermediate with the acyl donor (typically a phospholipid). This acyl group is subsequently transferred to the α-amino group of the lipoprotein's N-terminal cysteine, completing the triacylation process.
For experimental investigation of this function, researchers should:
Express the recombinant enzyme in a suitable system (often E. coli)
Purify it using appropriate detergents to maintain structure and function
Conduct in vitro assays with synthetic diacylated substrates and phospholipid donors
Monitor the formation of triacylated products using mass spectrometry or chromatographic techniques
Based on the available literature, recombinant Verminephrobacter eiseniae Apolipoprotein N-acyltransferase (lnt) is typically stored in a Tris/PBS-based buffer containing 6% Trehalose before lyophilization. This buffer composition helps maintain protein stability and activity.
When designing experimental protocols, researchers should consider:
Using Tris or phosphate-based buffers (pH 7.2-7.5) as the core buffer system
Including trehalose (5-7%) as a cryoprotectant for freeze-thaw stability
Adding mild detergents at concentrations above their critical micelle concentration to maintain protein solubility
Incorporating reducing agents (such as DTT or β-mercaptoethanol) to protect the catalytic cysteine residue
Testing the addition of glycerol (10-20%) for long-term storage stability
The specific buffer optimization should be experimentally determined based on activity assays and thermal stability measurements for each preparation of the recombinant enzyme.
Verminephrobacter eiseniae is a nephridial symbiont of earthworms (specifically Eisenia fetida), relying on motility factors like flagella and type IV pili for host colonization. The role of Lnt in this symbiotic relationship appears to be multifaceted, though still incompletely characterized.
To investigate this relationship methodologically:
Generate defined lnt knockout mutants: Use plasmid-based gene replacement strategies. The search results indicate that plasmids containing trfA and oriV from pVEIS01 (a related IncP-1 plasmid of V. eiseniae) are competent for replication in this organism . Include toxin-antitoxin systems like pemI/pemK for plasmid stability in the absence of selection .
Perform colonization assays: Compare the ability of wild-type and lnt-deficient V. eiseniae to colonize sterile earthworm nephridia. Quantify bacterial populations by microscopy or culture-based methods.
Analyze membrane integrity: Assess whether lnt mutation affects membrane properties that may be crucial for surviving host-derived stressors. Membrane permeability assays using fluorescent dyes can reveal structural defects.
Examine host immune responses: Investigate if triacylated lipoproteins produced by Lnt modulate Toll-like receptor signaling in the host, potentially influencing immune tolerance of the symbiont.
Study horizontal gene transfer: Explore how natural transformation, which has been demonstrated in V. eiseniae , might contribute to genetic variation in lnt and subsequent adaptation to the symbiotic lifestyle.
The connection between Lnt activity and antibiotic resistance has been suggested by research showing that loss of Lnt activity in Acinetobacter increases membrane permeability and antibiotic sensitivity. This relationship can be methodologically investigated in V. eiseniae through:
Minimum inhibitory concentration (MIC) determination:
Generate lnt mutants with various degrees of functional impairment
Test a panel of antibiotics with different mechanisms of action
Compare MIC values between wild-type and mutant strains
Focus particularly on antibiotics targeting cell envelope or requiring membrane penetration
Membrane permeability assays:
Use fluorescent probes that only enter cells with compromised membranes
Quantify fluorescence intensity as a measure of membrane integrity
Correlate permeability changes with antibiotic susceptibility patterns
Lipidomic analysis:
Conduct comprehensive lipid profiling of wild-type and lnt-deficient membranes
Identify changes in membrane composition that might affect antibiotic penetration
Use mass spectrometry to characterize changes in lipoproteins and other membrane components
Transcriptomic response:
Analyze global gene expression changes in response to lnt mutation
Identify compensatory mechanisms or stress responses activated
Look specifically for changes in expression of known antibiotic resistance genes
This methodological approach provides a framework for dissecting the mechanistic link between Lnt function and antibiotic resistance in V. eiseniae.
Understanding the catalytic mechanism of V. eiseniae Lnt requires detailed structural characterization. Based on available information about the enzyme's active site and conformational flexibility, the following methodological approaches are recommended:
X-ray crystallography:
Optimize protein expression and purification to obtain homogeneous preparations
Screen crystallization conditions, considering membrane protein-specific approaches
Use lipidic cubic phase crystallization for membrane proteins
Obtain structures in multiple states (apo, substrate-bound, product-bound)
Focus on the dynamic loops that regulate substrate access, as identified in E. coli Lnt structures
Site-directed mutagenesis of catalytic residues:
Target the catalytic cysteine equivalent to Cys387 in E. coli Lnt
Create systematic mutations of surrounding residues to map the complete active site
Assess enzymatic activity of each mutant to correlate structure with function
Use kinetic analysis to determine which step of the reaction is affected by each mutation
Enzyme-substrate complex characterization:
Design substrate analogs that form stable intermediates with the catalytic cysteine
Use mass spectrometry to identify covalent enzyme-substrate adducts
Attempt crystallization of these trapped intermediates
Combine with molecular dynamics simulations to model the catalytic cycle
Comparative structural analysis:
Analyze structural differences between V. eiseniae Lnt and homologs from other bacteria
Identify conserved and variable regions that might relate to substrate specificity
Construct chimeric enzymes to test functional hypotheses derived from structural comparisons
The expression and purification of functional recombinant V. eiseniae Lnt requires careful optimization due to its nature as a membrane protein. A methodological approach should consider:
Expression system selection:
Choose specialized E. coli strains designed for membrane protein expression (C41(DE3), C43(DE3))
Consider codon optimization of the lnt gene for the expression host
Design constructs with appropriate fusion tags (His-tag, MBP) to aid solubility and purification
Include TEV or PreScission protease sites for tag removal if needed
Induction and growth conditions:
Use lower temperatures (16-20°C) to promote proper folding
Implement gentle induction with reduced IPTG concentrations (0.1-0.5 mM)
Extend expression time (overnight to 24 hours) at lower temperatures
Consider auto-induction media for gradual protein expression
Membrane extraction and solubilization:
Carefully isolate membrane fractions through differential centrifugation
Test multiple detergents for optimal solubilization (DDM, CHAPS, LDAO)
Include glycerol (10-20%) to stabilize the protein during solubilization
Maintain reducing conditions to protect the catalytic cysteine
Purification strategy:
Use immobilized metal affinity chromatography (IMAC) as a first step
Follow with size exclusion chromatography to remove aggregates
Consider ion exchange chromatography for further purification if needed
Verify enzyme activity at each purification step
Storage conditions:
Use the Tris/PBS-based buffer with 6% Trehalose mentioned in the literature
Consider flash-freezing aliquots in liquid nitrogen
Validate enzyme stability under storage conditions through activity assays
The evidence that V. eiseniae mediates natural transformation provides an opportunity to study horizontal gene transfer of lnt. A methodological approach would include:
Natural transformation assays:
Develop protocols to measure transformation frequency in V. eiseniae
Prepare donor DNA containing lnt variants with selectable markers
Quantify transformation events under different environmental conditions
Analyze the integration patterns of acquired DNA
Comparative genomic analysis:
Obtain lnt sequences from various V. eiseniae isolates from different earthworm populations
Construct phylogenetic trees to identify potential horizontal gene transfer events
Calculate sequence divergence metrics (dN/dS ratios) to identify selection pressures
Compare gene synteny around the lnt locus across bacterial species
Experimental evolution studies:
Subject V. eiseniae populations to selective pressures relevant to lnt function
Monitor genetic changes in lnt over multiple generations
Sequence evolved populations to detect acquisition of novel lnt variants
Correlate genetic changes with phenotypic adaptations
Functional validation of transferred genes:
Express and characterize lnt variants acquired through horizontal transfer
Compare enzymatic properties with the original V. eiseniae Lnt
Assess whether acquired variants confer adaptive advantages
Test complementation of lnt mutants with horizontally acquired variants
This methodological framework leverages the natural transformation capability of V. eiseniae to understand the evolution and diversification of lnt genes in this symbiotic bacterium.
Investigating how Lnt affects membrane integrity and stress responses requires a multi-faceted approach:
Generation of conditional lnt mutants:
Membrane permeability assessment:
Employ fluorescent dyes (propidium iodide, SYTOX Green) to quantify permeability changes
Measure uptake of normally excluded compounds as indicators of membrane defects
Use fluorescence microscopy and flow cytometry for single-cell analysis of permeability
Lipidomic analysis under stress conditions:
Expose wild-type and lnt-deficient strains to relevant stressors (host-derived compounds, pH shifts)
Perform comprehensive lipidomic profiling using LC-MS/MS
Compare lipid compositions under normal and stress conditions
Identify compensatory changes in membrane composition
Transcriptomic and proteomic responses:
Conduct RNA-seq analysis to identify differentially expressed genes in lnt mutants
Focus on stress response pathways and membrane homeostasis mechanisms
Validate key findings with targeted protein expression analysis
Construct reporter fusions to monitor stress response activation in real-time
Host-relevant stress tolerance:
Test survival under conditions mimicking the earthworm nephridial environment
Assess resistance to antimicrobial peptides and other host defense molecules
Measure biofilm formation capacity as a stress response mechanism
Investigate cell envelope integrity under osmotic or oxidative stress
This methodological framework provides a comprehensive approach to understanding how Lnt contributes to membrane integrity and stress adaptation in V. eiseniae.
A comparative analysis of V. eiseniae Lnt with homologs from other bacteria can provide insights into species-specific adaptations and conserved mechanisms. The methodological approach should include:
Sequence alignment and phylogenetic analysis:
Collect Lnt sequences from diverse bacterial taxa
Perform multiple sequence alignments to identify conserved and variable regions
Construct phylogenetic trees to visualize evolutionary relationships
Map known functional residues (e.g., the catalytic cysteine) onto the alignment
Structural comparison:
Use homology modeling to predict the structure of V. eiseniae Lnt based on E. coli Lnt crystal structures
Analyze conservation of active site architecture and substrate-binding regions
Identify structural differences that might relate to substrate specificity or environmental adaptation
Focus on the dynamic loops that regulate substrate access, as mentioned in the search results
Functional complementation studies:
Construct expression vectors containing lnt genes from various bacterial species
Test their ability to complement an lnt-deficient V. eiseniae strain
Analyze which homologs restore wild-type phenotypes and which fail
Correlate complementation ability with sequence/structural features
Biochemical characterization:
Express and purify Lnt from V. eiseniae and selected comparison species
Compare enzymatic parameters (Km, kcat, substrate preference)
Test activity under different conditions (pH, temperature, ionic strength)
Identify species-specific functional adaptations
This comparative approach can reveal how V. eiseniae Lnt has evolved in the context of its symbiotic lifestyle with earthworms compared to homologs from free-living or pathogenic bacteria.
The search results indicate that plasmids containing trfA and oriV from pVEIS01, a related IncP-1 plasmid of V. eiseniae, are competent for replication in this organism . This provides valuable information for developing genetic tools:
Shuttle vector development:
Design vectors incorporating the V. eiseniae trfA and oriV elements for replication
Include the pemI/pemK toxin-antitoxin system to improve plasmid stability in the absence of selection
Add appropriate selection markers and multiple cloning sites
Test replication efficiency in both V. eiseniae and E. coli
Expression control systems:
Develop inducible promoter systems compatible with V. eiseniae
Create lnt expression constructs with varying promoter strengths
Design systems for controlled depletion of Lnt to study its essential functions
Validate expression systems using reporter genes before applying to lnt
Gene replacement strategies:
Use plasmid-based approaches for targeted modification of the chromosomal lnt gene
Design constructs for allelic exchange to introduce specific mutations
Create conditional lnt mutants for studying essential functions
Implement CRISPR-Cas9 systems adapted for V. eiseniae
Dual-function elements:
Combine replication and stability elements into minimal functional units
Test compatibility with various expression cassettes
Optimize vector size to improve transformation efficiency
Develop standardized modular components for genetic manipulation
This methodological framework leverages the known plasmid biology of V. eiseniae to develop effective genetic tools for manipulating Lnt expression and studying its function in this symbiotic bacterium.
High-throughput methodologies can systematically explore Lnt substrate preferences and catalytic parameters:
Substrate library screening:
Generate libraries of synthetic diacylated lipoprotein substrates with variations in:
N-terminal amino acid sequence
Acyl chain composition of the diacylglycerol moiety
Protein size and structure
Develop a high-throughput assay to measure N-acylation efficiency
Identify substrate features that enhance or inhibit Lnt activity
Phospholipid donor screening:
Test diverse phospholipids as acyl donors with varying:
Head group chemistry
Acyl chain length and saturation
Membrane fluidity characteristics
Employ mass spectrometry to identify the transferred acyl groups
Correlate donor preferences with the natural phospholipid composition of V. eiseniae membranes
Deep mutational scanning:
Create comprehensive libraries of Lnt variants with single amino acid substitutions
Develop selection or screening systems to identify variants with altered activity
Map mutations affecting substrate specificity onto structural models
Use machine learning to predict specificity determinants from sequence-function relationships
Proteomics identification of natural substrates:
Compare the lipoprotein profiles of wild-type and lnt-deficient V. eiseniae
Identify proteins that show altered N-terminal acylation
Characterize common features of preferred substrates in vivo
Correlate substrate utilization with functional pathways
This methodological framework provides a systematic approach to understanding the substrate preferences of V. eiseniae Lnt, which could reveal adaptations specific to its symbiotic lifestyle.
Recombinant V. eiseniae Lnt could be leveraged for various synthetic biology applications:
Engineered membrane protein display systems:
Develop platforms using Lnt-mediated N-acylation for membrane anchoring
Create modular expression systems combining signal peptides, lipidation sites, and cargo proteins
Optimize surface display of functional proteins in bacterial systems
Apply to vaccine development, biocatalysis, and biosensor design
Cell-free lipoprotein synthesis:
Establish in vitro systems for producing triacylated lipoproteins
Combine recombinant Lnt with other lipoprotein processing enzymes
Control acylation patterns by providing defined phospholipid donors
Use for studying lipoprotein-receptor interactions without cellular complexity
Metabolic engineering applications:
Exploit Lnt to create membrane-anchored enzyme cascades
Enhance substrate channeling through spatial organization of reaction components
Improve stability of industrial enzymes through membrane association
Develop new approaches for whole-cell biocatalysis
Bionanotechnology platforms:
Create lipid nanoparticles with controlled protein display
Develop self-assembling systems using Lnt-processed lipoproteins
Design biomimetic interfaces for medical and materials applications
Engineer bacterial outer membrane vesicles with tailored surface properties
This methodological approach to synthetic biology applications leverages the unique properties of V. eiseniae Lnt, potentially leading to novel biotechnological tools and platforms.